June 29 (Reuters) – Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its oncology pipeline with a late-stage blood cancer treatment, the French biotech company said on Monday.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VMPLNew Delhi [India], June 29: As generative AI reshapes industries globally, India's land and property…
Cricket's return to the Olympic Games is a landmark moment: ICC Chairman Jay Shah
New Delhi [India], June 29 (ANI): International Cricket Council (ICC) Chairman Jay Shah called cricket's…
‘Aghru Chhe Yaar’ Gears Up for July 3 Release After Trailer Crosses 2 Million Views
Ahmedabad (Gujarat) [India], June 29: Gujarati cinema is steadily embracing a new era of emotionally…
